FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1179-1184 April 28, 1994 Number 17 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis.

Methods We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel.

Results A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P<0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P<0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P<0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P<0.001).

Conclusions The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.

Source Information

From the Research Division (S.E.W., M.N.), the Division of Pulmonary-Critical Care (P.C.S., B.H.F.), and the Division of Infectious Disease (F.X.B.), Department of Medicine, University of North Texas Health Science Center at Fort Worth; the Fort Worth-Tarrant County Health Department (S.E.W., B.K., G.B.M.); and John Peter Smith Hospital (E.G.) -- all in Fort Worth, Tex.

Address reprint requests to Dr. Weis at the Research Division, Department of Medicine, University of North Texas Health Science Center at Fort Worth, Suite 232-ME2, 3500 Camp Bowie, Fort Worth, TX 76107.

Full Text of this Article

This article has been cited by other articles:

• Gaensbauer, J T, Ni Chroinin, M (2009). "What we learn in time of pestilence...". EDUCATION AND PRACTICE 94: 108-114 [Full Text]  
• Schluger, N. W. (2007). Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?. Eur Respir J 30: 825-827 [Full Text]  
• Wood, R., Middelkoop, K., Myer, L., Grant, A. D., Whitelaw, A., Lawn, S. D., Kaplan, G., Huebner, R., McIntyre, J., Bekker, L.-G. (2007). Undiagnosed Tuberculosis in a Community with High HIV Prevalence: Implications for Tuberculosis Control. Am. J. Respir. Crit. Care Med. 175: 87-93 [Abstract] [Full Text]  
• Koenig, S. P, Kuritzkes, D. R, Hirsch, M. S, Leandre, F., Mukherjee, J. S, Farmer, P. E, del Rio, C. (2006). Monitoring HIV treatment in developing countries. BMJ 332: 602-604 [Full Text]  
• Frieden, T. R. (2006). Lack of Directly Observed Treatment Affects Tuberculosis Relapse Rates. Am. J. Respir. Crit. Care Med. 173: 359-359 [Full Text]  
• (2005). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States. Am. J. Respir. Crit. Care Med. 172: 1169-1227 [Full Text]  
• Jasmer, R. M., Seaman, C. B., Gonzalez, L. C., Kawamura, L. M., Osmond, D. H., Daley, C. L. (2004). Tuberculosis Treatment Outcomes: Directly Observed Therapy Compared with Self-Administered Therapy. Am. J. Respir. Crit. Care Med. 170: 561-566 [Abstract] [Full Text]  
• Griffith, D. E. (2004). Treatment of Multidrug-resistant Tuberculosis: Should You Try This at Home?. Am. J. Respir. Crit. Care Med. 169: 1082-1083 [Full Text]  
• Ranjbar, S., Ly, N., Thim, S., Reynes, J.-M., Goldfeld, A. E. (2004). Mycobacterium tuberculosis Recall Antigens Suppress HIV-1 Replication in Anergic Donor Cells via CD8+ T Cell Expansion and Increased IL-10 Levels. J. Immunol. 172: 1953-1959 [Abstract] [Full Text]  
• Cahn, P., Perez, H., Ben, G., Ochoa, C. (2003). Tuberculosis and HIV: A Partnership Against the Most Vulnerable. J Int Assoc Physicians AIDS Care (Chic Ill) 2: 106-123 [Abstract]  
• (2003). Post-Detention Completion of Tuberculosis Treatment for Persons Deported or Released from the Custody of the Immigration and Naturalization Service--United States, 2003. JAMA 289: 3081-3082 [Full Text]  
• (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. Am. J. Respir. Crit. Care Med. 167: 603-662 [Full Text]  
• Broekmans, J.F., Migliori, G.B., Rieder, H.L., Lees, J., Ruutu, P., Loddenkemper, R., Raviglione, M.C. (2002). European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 19: 765-775 [Abstract] [Full Text]  
• Abbadi, S., Rashed, H. G., Morlock, G. P., Woodley, C. L., El Shanawy, O., Cooksey, R. C. (2001). Characterization of IS6110 Restriction Fragment Length Polymorphism Patterns and Mechanisms of Antimicrobial Resistance for Multidrug-Resistant Isolates of Mycobacterium tuberculosis from a Major Reference Hospital in Assiut, Egypt. J. Clin. Microbiol. 39: 2330-2334 [Abstract] [Full Text]  
• Hwang, S. W. (2001). Homelessness and health. CMAJ 164: 229-233 [Abstract] [Full Text]  
• Lobato, M. N., Mohle-Boetani, J. C., Royce, S. E. (2000). Missed Opportunities for Preventing Tuberculosis Among Children Younger Than Five Years of Age. Pediatrics 106: 75e-75 [Abstract] [Full Text]  
• MATTEELLI, A., CASALINI, C., RAVIGLIONE, M. C., EL-HAMAD, I., SCOLARI, C., BOMBANA, E., BUGIANI, M., CAPUTO, M., SCARCELLA, C., CAROSI, G. (2000). Supervised Preventive Therapy for Latent Tuberculosis Infection in Illegal Immigrants in Italy. Am. J. Respir. Crit. Care Med. 162: 1653-1655 [Abstract] [Full Text]  
• Horsburgh, C. R. Jr (2000). The Global Problem of Multidrug-Resistant Tuberculosis: The Genie Is out of the Bottle. JAMA 283: 2575-2576 [Full Text]  
• Garcia-Garcia, M. d. L., Ponce-de-Leon, A., Jimenez-Corona, M. E., Jimenez-Corona, A., Palacios-Martinez, M., Balandrano-Campos, S., Ferreyra-Reyes, L., Juarez-Sandino, L., Sifuentes-Osornio, J., Olivera-Diaz, H., Valdespino-Gomez, J. L., Small, P. M. (2000). Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico. Arch Intern Med 160: 630-636 [Abstract] [Full Text]  
• Granich, R. M., Balandrano, S., Santaella, A. J., Binkin, N. J., Castro, K. G., Marquez-Fiol, A., Anzaldo, G., Zarate, M., Jaimes, M. L., Velazquez-Monroy, O., Salazar, L., Alvarez-Lucas, C., Kuri, P., Flisser, A., Santos-Preciado, J., Ruiz-Matus, C., Tapia-Conyer, R., Tappero, J. W. (2000). Survey of Drug Resistance of Mycobacterium tuberculosis in 3 Mexican States, 1997. Arch Intern Med 160: 639-644 [Abstract] [Full Text]  
• Tulsky, J. P., Pilote, L., Hahn, J. A., Zolopa, A. J., Burke, M., Chesney, M., Moss, A. R. (2000). Adherence to Isoniazid Prophylaxis in the Homeless: A Randomized Controlled Trial. Arch Intern Med 160: 697-702 [Abstract] [Full Text]  
• Laserson, K. F., Iademarco, M. F. (2000). Profiling Drug Resistance in Immigrants With Tuberculosis. Chest 117: 623-625 [Full Text]  
• Schraufnagel, D., Abubaker, J., Heymann, S. J., Brewer, T. F., Wilson, M. E., Fineberg, H. V. (2000). Global Action Against Multidrug-Resistant Tuberculosis. JAMA 283: 54-55 [Full Text]  
• Liu, Z., Shilkret, K. L., Ellis, H. M. (1999). Predictors of Sputum Culture Conversion Among Patients With Tuberculosis in the Era of Tuberculosis Resurgence. Arch Intern Med 159: 1110-1116 [Abstract] [Full Text]  
• Leung, A. N. (1999). Pulmonary Tuberculosis: The Essentials. Radiology 210: 307-322 [Full Text]  
• LoBue, P. A., Cass, R., Lobo, D., Moser, K., Catanzaro, A. (1999). Development of Housing Programs to Aid in the Treatment of Tuberculosis in Homeless Individuals: A Pilot Study. Chest 115: 218-223 [Abstract] [Full Text]  
• Lerner, B. H. (1999). Catching Patients: Tuberculosis and Detention in the 1990s. Chest 115: 236-241 [Abstract] [Full Text]  
• Bishai, W. R., Graham, N. M. H., Harrington, S., Pope, D. S., Hooper, N., Astemborski, J., Sheely, L., Vlahov, D., Glass, G. E., Chaisson, R. E. (1998). Molecular and Geographic Patterns of Tuberculosis Transmission After 15 Years of Directly Observed Therapy. JAMA 280: 1679-1684 [Abstract] [Full Text]  
• Pablos-Mendez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S.B., Kim, S. J., Chaulet, P., Nunn, P., The World Health Organization-International Union, (1998). Global Surveillance for Antituberculosis-Drug Resistance, 1994-1997. NEJM 338: 1641-1649 [Abstract] [Full Text]  
• McKeogh, M. M (1997). Tuberculosis in the hospice a cause for concern?. Palliat Med 11: 469-474 [Abstract]  
• Goad, J., Jaresko, G. (1997). Tuberculosis in the 90's. Journal of Pharmacy Practice 10: 105-121  
• Fujiwara, P. I., Cook, S. V., Rutherford, C. M., Crawford, J. T., Glickman, S. E., Kreiswirth, B. N., Sachdev, P. S., Osahan, S. S., Ebrahimzadeh, A., Frieden, T. R. (1997). A Continuing Survey of Drug-Resistant Tuberculosis, New York City, April 1994. Arch Intern Med 157: 531-536 [Abstract]  
• Frieden, T. R., Sherman, L. F., Maw, K. L. (1997). Highly Drug-Resistant Tuberculosis-Reply. JAMA 277: 629-629 [Abstract]  
• Abernathy, R. S. (1997). Tuberculosis: An Update. Pediatr. Rev. 18: 50-58 [Full Text]  
• Pulido, F., Pena, J.-M., Rubio, R., Moreno, S., Gonzalez, J., Guijarro, C., Costa, J.-R., Vazquez, J.-J. (1997). Relapse of Tuberculosis After Treatment in Human Immunodeficiency Virus--Infected Patients. Arch Intern Med 157: 227-232 [Abstract]  
• De Cock, K. M., Binkin, N. J., Zuber, P. L. F., Tappero, J. W., Castro, K. G. (1996). Research Issues Involving HIV-Associated Tuberculosis in Resource-Poor Countries. JAMA 276: 1502-1507 [Abstract]  
• Kohn, M. R., Arden, M. R., Vasilakis, J., Shenker, I. R. (1996). Directly Observed Preventive Therapy: Turning the Tide Against Tuberculosis. Arch Pediatr Adolesc Med 150: 727-729 [Abstract]  
• Bishai, W. R., Graham, N. M.H., Harrington, S., Page, C., Moore-Rice, K., Hooper, N., Chaisson, R. E. (1996). Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis. NEJM 334: 1573-1576 [Full Text]  
• Morse, D. I (1996). Directly observed therapy for tuberculosis. BMJ 312: 719-720 [Full Text]  
• Bifani, P. J., Plikaytis, B. B., Kapur, V., Stockbauer, K., Pan, X., Lutfey, M. L., Moghazeh, S. L., Eisner, W., Daniel, T. M., Kaplan, M. H., Crawford, J. T., Musser, J. M., Kreiswirth, B. N. (1996). Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family. JAMA 275: 452-457 [Abstract]  
• Bloch, A. B., Simone, P. M., McCray, E., Castro, K. G. (1996). Preventing Multidrug-Resistant Tuberculosis. JAMA 275: 487-489 [Abstract]  
• Chaulk, C. P., Moore-Rice, K., Rizzo, R., Chaisson, R. E. (1995). Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis. JAMA 274: 945-951 [Abstract]  
• Brown, R. E., Miller, B., Taylor, W. R., Palmer, C., Bosco, L., Nicola, R. M., Zelinger, J., Simpson, K. (1995). Health-Care Expenditures for Tuberculosis in the United States. Arch Intern Med 155: 1595-1600 [Abstract]  
• Frieden, T. R., Fujiwara, P. I., Washko, R. M., Hamburg, M. A. (1995). Tuberculosis in New York City -- Turning the Tide. NEJM 333: 229-233 [Abstract] [Full Text]  
• Millard, J., Rayner, C. (1995). Increase in incidence of tuberculosis. BMJ 311: 122b-122 [Full Text]  
• (1995). Drug-resistant tuberculosis. DTB 33: 28-29 [Abstract] [Full Text]  
• Patel, K. B., Belmonte, R., Crowe, H. M. (1995). Drug Malabsorption and Resistant Tuberculosis in HIV-Infected Patients. NEJM 332: 336-337 [Full Text]  
• Bloch, A. B., Sumartojo, E., Castro, K. G. (1994). Directly Observed Therapy for Tuberculosis in New York City-Reply. JAMA 272: 436-436 [Abstract]  
• (1994). Expanded Tuberculosis Surveillance and Tuberculosis Morbidity--United States, 1993. JAMA 272: 265-266  
• Hamburg, M. A., Frieden, T. R. (1994). Tuberculosis Transmission in the 1990s. NEJM 330: 1750-1751 [Full Text]  
• Murray, B. E. (1994). Can Antibiotic Resistance be Controlled?. NEJM 330: 1229-1230 [Full Text]